Literature DB >> 24354373

How to perform parathyroid 4D CT: tips and traps for technique and interpretation.

Jenny K Hoang1, Won-kyung Sung, Manisha Bahl, C Douglas Phillips.   

Abstract

Parathyroid four-dimensional (4D) computed tomography (CT) is an imaging technique for preoperative localization of parathyroid adenomas that involves multidetector CT image acquisition during two or more contrast enhancement phases. Four-dimensional CT offers an alternative or additional tool in the evaluation of primary hyperparathyroidism. The purpose of this article is to describe the 4D CT technique and provide a practical guide to the radiologist for imaging interpretation. The article will discuss the rationale for imaging, approach to interpretation, imaging findings, and pitfalls. © RSNA, 2014.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24354373     DOI： 10.1148/radiol.13122661

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


  36 in total

1.  Effect of tumor volume on the enhancement pattern of parathyroid adenoma on parathyroid four-dimensional CT.

Authors:  Eun Kyoung Lee; Tae Jin Yun; Ji-Hoon Kim; Kyu Eun Lee; Su-Jin Kim; Jae-Kyung Won; Koung Mi Kang; Seung Hong Choi; Chul-Ho Sohn
Journal:  Neuroradiology       Date:  2016-02-05       Impact factor: 2.804

2.  4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism.

Authors:  J L Becker; V Patel; K J Johnson; M Guerrero; R R Klein; G F Ranvier; R P Owen; P Pawha; K Nael
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-12       Impact factor: 3.825

3.  MR appearance of parathyroid adenomas at 3 T in patients with primary hyperparathyroidism: what radiologists need to know for pre-operative localization.

Authors:  B Sacconi; R Argirò; Daniele Diacinti; A Iannarelli; M Bezzi; C Cipriani; D Pisani; V Cipolla; C De Felice; S Minisola; C Catalano
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

4.  CT features of parathyroid carcinomas: comparison with benign parathyroid lesions.

Authors:  Koji Takumi; Yoshihiko Fukukura; Hiroto Hakamada; Hiroaki Nagano; Yuichi Kumagae; Hideo Arima; Akihiro Nakajo; Takashi Yoshiura
Journal:  Jpn J Radiol       Date:  2019-03-12       Impact factor: 2.374

5.  Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism.

Authors:  Randy Yeh; Yu-Kwang Donovan Tay; Gaia Tabacco; Laurent Dercle; Jennifer H Kuo; Leonardo Bandeira; Catherine McManus; David K Leung; James A Lee; John P Bilezikian
Journal:  Radiology       Date:  2019-03-05       Impact factor: 11.105

Review 6.  Endocrine tumors associated with the vagus nerve.

Authors:  Arthur Varoquaux; Electron Kebebew; Fréderic Sebag; Katherine Wolf; Jean-François Henry; Karel Pacak; David Taïeb
Journal:  Endocr Relat Cancer       Date:  2016-07-12       Impact factor: 5.678

7.  Dynamic CT for parathyroid disease: are multiple phases necessary?

Authors:  P Raghavan; C R Durst; D A Ornan; S Mukherjee; M Wintermark; J T Patrie; W Xin; A L Shada; J B Hanks; P W Smith
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-05       Impact factor: 3.825

8.  Detection of parathyroid adenomas using a monophasic dual-energy computed tomography acquisition: diagnostic performance and potential radiation dose reduction.

Authors:  Carlos Leiva-Salinas; Lucia Flors; Christopher R Durst; Qinghua Hou; James T Patrie; Max Wintermark; Sugoto Mukherjee
Journal:  Neuroradiology       Date:  2016-09-02       Impact factor: 2.804

9.  Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome.

Authors:  Francesco Tonelli; Carlo Biagini; Francesco Giudici; Federica Cioppi; Maria Luisa Brandi
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

10.  Clinical Images: Four-Dimensional Computed Tomography-Future of Preoperative Parathyroid Adenoma Imaging.

Authors:  Charles Matthews; Andrew Matthews; Kurosh Safavi
Journal:  Ochsner J       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.